Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 3
1 (50.0%)An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data
Completed
- Conditions
- Reproductive IssuesReproductive DisorderGynecologic DiseaseFertility DisordersFertility IssuesIVF
- Interventions
- Drug: Follicle Stimulating Hormone/Luteinizing Hormone
- First Posted Date
- 2021-04-22
- Last Posted Date
- 2021-10-22
- Lead Sponsor
- IVFarma LLC
- Target Recruit Count
- 5484
- Registration Number
- NCT04854707
- Locations
- 🇷🇺
Center for reproductive medicine, Barnaul, Barnaul, Russian Federation
🇷🇺Clinical Institute of Reproductive Medicine, Ekaterinburg, Russian Federation
🇷🇺Center for reproductive medicine, Irkutsk, Irkutsk, Russian Federation
The Safety and Pharmacokinetics of Primapur and Gonal-f
Phase 1
Completed
- Conditions
- AbsorptionPharmacokineticsArea Under Curve
- Interventions
- First Posted Date
- 2019-02-27
- Last Posted Date
- 2019-08-13
- Lead Sponsor
- IVFarma LLC
- Target Recruit Count
- 28
- Registration Number
- NCT03857230
- Locations
- 🇷🇺
O.M. Filatov Municipal Clinical Hospital N 15, Moscow, Russian Federation
Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment
Phase 3
Completed
- Conditions
- Infertility, Female
- Interventions
- First Posted Date
- 2017-03-23
- Last Posted Date
- 2022-04-01
- Lead Sponsor
- IVFarma LLC
- Target Recruit Count
- 118
- Registration Number
- NCT03088137
- Locations
- 🇷🇺
Clinical Hospital Lapino, Moscow Oblast, Russian Federation
🇷🇺AltraVita IVF clinic, Moscow, Russian Federation
🇷🇺Perinatal Medical Center, Moscow, Russian Federation
News
No news found